ExploreInsights

Isaac Cheng

Director

Dr. Cheng joined Morningside in 2006 and focuses on biopharmaceutical and healthcare investments. He is currently a director of Liquidia Technologies, Cognoa, K-Gen, Artugen Therapeutics, Cognito Therapeutics, Amylyx Pharmaceuticals, and NuCana BioMed. Previously he was a board member of Advanced Cell Diagnostics (sold to Bio-Techne). Prior to j...

Roles at Amylyx

  • Director

    Current role

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.